James H. Mackaness - 27 Mar 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Signature
/s/ James Mackaness
Issuer symbol
SLNO
Transactions as of
27 Mar 2025
Net transactions value
-$5,473,052
Form type
4
Filing time
31 Mar 2025, 19:20:00 UTC
Previous filing
23 Jan 2025
Next filing
17 Dec 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale $110,102 -1,669 -1.3% $65.97 124,129 27 Mar 2025 Direct F1, F2, F3
transaction SLNO Common Stock Sale $181,473 -2,717 -2.2% $66.79 121,412 27 Mar 2025 Direct F1, F3, F4
transaction SLNO Common Stock Sale $334,441 -4,940 -4.1% $67.70 116,472 27 Mar 2025 Direct F1, F3, F5
transaction SLNO Common Stock Sale $446,985 -6,498 -5.6% $68.79 109,974 27 Mar 2025 Direct F1, F3, F6
transaction SLNO Common Stock Sale $262,727 -3,762 -3.4% $69.84 106,212 27 Mar 2025 Direct F1, F3, F7
transaction SLNO Common Stock Sale $27,374 -387 -0.36% $70.73 105,825 27 Mar 2025 Direct F1, F3, F8
transaction SLNO Common Stock Sale $40,391 -563 -0.53% $71.74 105,262 27 Mar 2025 Direct F1, F3, F9
transaction SLNO Common Stock Sale $6,247 -86 -0.08% $72.64 105,176 27 Mar 2025 Direct F1, F3, F10
transaction SLNO Common Stock Options Exercise $615,000 +20,000 +19% $30.75 125,176 27 Mar 2025 Direct F3
transaction SLNO Common Stock Options Exercise $51,000 +10,000 +8% $5.10 135,176 27 Mar 2025 Direct F3
transaction SLNO Common Stock Options Exercise $12,975 +5,000 +3.7% $2.60 140,176 27 Mar 2025 Direct F3
transaction SLNO Common Stock Options Exercise $36,150 +15,000 +11% $2.41 155,176 27 Mar 2025 Direct F3
transaction SLNO Common Stock Options Exercise $105,000 +20,000 +13% $5.25 175,176 27 Mar 2025 Direct F3
transaction SLNO Common Stock Sale $1,782,022 -25,799 -15% $69.07 149,377 27 Mar 2025 Direct F3, F11
transaction SLNO Common Stock Sale $2,531,919 -36,157 -24% $70.03 113,220 27 Mar 2025 Direct F3, F12
transaction SLNO Common Stock Sale $569,494 -8,044 -7.1% $70.80 105,176 27 Mar 2025 Direct F3, F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -20,000 -100% $0.000000 0 27 Mar 2025 Common Stock 20,000 $30.75 Direct F14
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -10,000 -77% $0.000000 3,000 27 Mar 2025 Common Stock 10,000 $5.10 Direct F15
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -5,000 -100% $0.000000 0 27 Mar 2025 Common Stock 5,000 $2.60 Direct F14
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -15,000 -50% $0.000000 15,000 27 Mar 2025 Common Stock 15,000 $2.41 Direct F16
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -20,000 -23% $0.000000 67,251 27 Mar 2025 Common Stock 20,000 $5.25 Direct F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F4 This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 This transaction was executed in multiple trades at prices ranging from $68.48 to $69.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F12 This transaction was executed in multiple trades at prices ranging from $69.48 to $70.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F13 This transaction was executed in multiple trades at prices ranging from $70.49 to $71.175. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F14 All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F15 One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of January 1, 2022 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date.
F16 One forty-eighth of the shares subject to the option vest on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F17 One thirty-sixth of the shares subject to the Option vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.